development, Author at DDReg pharma

Quality Management Maturity Program by the CDER of the U.S. FDA

All Category, Blogs, Pharmacovigilance / development

The pharmaceutical industry is one that is constantly growing and simultaneously facing challenges in Quality Management Maturity Program in US FDA. The onset of the pandemic has brought new obstacles that require immediate attention and innovative solutions. Quality assurance (QA) is a routine measure that ultimately ensures patient safety by making sure all pharmaceutical products […]

Quality Management Maturity Program by the CDER of the U.S. FDA Read More »

Technological Transformation in Pharmacovigilance

All Category, Insights, Pharmacovigilance / development

Technological disruption is rapidly occurring across all industries. In the pharmaceutical industry, technological contenders are gradually transforming the landscape of drug development, clinical trials, and pre-clinical phases. Indeed, this holds true for Transformation Pharmacovigilance and drug safety monitoring. Though the area of the industry is niche and highly regulated, hence the apprehension in incorporating technology

Technological Transformation in Pharmacovigilance Read More »

Regulatory Compliance Outsourcing Solutions

All Category, Blogs / development

In an era of technological advancement, and easy access to such disruptors, pharmaceutical organizations are increasingly looking to outsource their solutions to enhance efficiency and reduce cost. Inevitably, there are many benefits to Regulatory Compliance Outsourcing in the pharmaceutical industry that include operational control, faster time-to-market, increased flexibility & revenue, quality production and ultimately lead

Regulatory Compliance Outsourcing Solutions Read More »

DDReg attends National Conference on Pharmacovigilance and Clinical Research 2022- Chandigarh College of Pharmacy

All Category, News and Events / development

Drug abuse has gradually become an increasing issue due to the use of non-medical prescription drugs. Thus, pharmacovigilance and drug safety has become an even more crucial aspect for ensuring patient safety by monitoring adverse drug reactions and evaluating the safe use of medicines. To do this, robust procedures must be established while keeping in

DDReg attends National Conference on Pharmacovigilance and Clinical Research 2022- Chandigarh College of Pharmacy Read More »

Nanobodies vs Antibodies in the Fight Against Covid

All Category, Insights, Medical Writing / development

Nanobodies are engineered small proteins that recognize and specifically bind to an antigen to initiate an appropriate signal- like antibodies. However, nanobodies bind to antigens with greater specificity and display other advantages over conventional antibodies. Extracted from camelids, these antibodies were found to comprise only of heavy chains, while demonstrating the same functions as conventional

Nanobodies vs Antibodies in the Fight Against Covid Read More »

Enhancing Drug Discovery Process Through Artificial Intelligence

All Category, Insights, Medical Writing / development

From pre-clinical phases to post-marketing follow-up studies, the drug development process is a challenging, expensive, and time-consuming process that can take many years to complete. Companies spend millions of dollars and countless hours to test the effectiveness of their new drugs. To save cost and time, pharmaceutical companies are incorporating ai in drug discovery process

Enhancing Drug Discovery Process Through Artificial Intelligence Read More »

DDReg to participate in CPhI North America conference in Philadelphia from 17th-19th May, 2022

All Category, News and Events / development

CPhI provides a networking platform for pharmaceutical industry leaders. As America accounts for approximately 40% of global pharmaceutical sales, CPhI North America is the ideal event that encourages pharmaceutical experts to interact with each other regarding innovation within the industry. The 3-day, in-person, conference will touch on a broad horizon of relevant topics including market

DDReg to participate in CPhI North America conference in Philadelphia from 17th-19th May, 2022 Read More »

Why QPPV Training is the Key to Pharmacovigilance Success?

All Category, Blogs, Pharmacovigilance / development

Drug safety is all about the right patient receiving the right drug at the right time for an improved outcome for each patient. To achieve this, a Qualified Person Responsible for Pharmacovigilance (QPPV) Training is held responsible for the pharmacovigilance services management of the quality of a pharmaceutical company. This could be a person who

Why QPPV Training is the Key to Pharmacovigilance Success? Read More »

Impact of Russia Ukraine war on clinical Trails

The impact of the Russia-Ukraine war on clinical trials

All Category, Insights, Regulatory / development

The Russia-Ukraine war has undoubtedly affected millions of people in and around the world. Several industries have taken a huge hit where operational and business continuity has been threatened, the pharmaceutical industry being one of them. From the delays along the drug development pipeline, to non-compliance products in the market being at risk, the industry

The impact of the Russia-Ukraine war on clinical trials Read More »

The First WHO Global Centre For Traditional Medicine in Gujurat, India

All Category, Insights, Pharmacovigilance / development

The 7th of April 2022 marked the 74th anniversary of the founding of WHO in 1948 which is celebrated annually as ‘World Health Day’. Each year draws attention to a specific health topic of concern to people all over the world. The onset of the pandemic has created history and has affected billions of people

The First WHO Global Centre For Traditional Medicine in Gujurat, India Read More »

Author name: development